Literature DB >> 16775543

The relationship of a 6-min walk to VO(2 peak) and VT in older heart failure patients.

Sara Maldonado-Martín1, Peter H Brubaker, Leonard A Kaminsky, J Brian Moore, Kathryn P Stewart, Dalane W Kitzman.   

Abstract

PURPOSE: To evaluate the relationship between a 6-min walk test (6-MWT) to peak oxygen consumption (VO(2 peak)) and ventilatory threshold (VT) in older heart failure (HF) patients, to validate the equation by Cahalin et al., and to develop a new equation to improve the prediction of VO(2 peak) from 6-MWT.
METHODS: Older patients (>65 yr) with systolic or diastolic HF (N=97) performed an exercise test to peak exertion on an upright bicycle ergometer using an incremental protocol. Gas exchange measures were collected along with continuous electrocardiograph monitoring. 6-MWT was performed on an indoor track at a self-selected pace under standardized conditions. The formula of Cahalin et al. was used to predict VO(2 peak) from 6-MWT, and a new equation was generated from the measured VO(2 peak)-6-MWT relationship from this investigation.
RESULTS: The correlation between 6-MWT and measured VO(2 peak) was moderate (r=0.54) with a standard error of estimate (SEE) of 2.48 mL.kg.min. The correlation between 6-MWT and VT was weak (r=0.23), whereas the correlation between VO(2 peak) and VT was strong (r=0.74). Correlations between the measured and predicted VO(2 peak) values were moderate (r=0.54) for both prediction equations, and the SEE was 2.83 versus 1.34 mL.kg.min for the Cahalin et al. and the new equation, respectively.
CONCLUSION: These results indicate that 6-MWT does not accurately predict functional capacity in older HF patients, and questions the validity of using this test to determine functional capacity in older HF patients. Predicting VO(2 peak) from equations using 6-MWT also results in substantial variability and, consequently, should not be used in older HF patients where an accurate determination of functional capacity is essential.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775543     DOI: 10.1249/01.mss.0000222830.41735.14

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  7 in total

Review 1.  Exercise intolerance.

Authors:  Dalane W Kitzman; Leanne Groban
Journal:  Heart Fail Clin       Date:  2008-01       Impact factor: 3.179

2.  Exercise intolerance.

Authors:  Dalane W Kitzman; Leanne Groban
Journal:  Cardiol Clin       Date:  2011-08       Impact factor: 2.213

3.  Endurance exercise training in older patients with heart failure: results from a randomized, controlled, single-blind trial.

Authors:  Peter H Brubaker; J Brian Moore; Kathryn P Stewart; Debra J Wesley; Dalane W Kitzman
Journal:  J Am Geriatr Soc       Date:  2009-11       Impact factor: 5.562

4.  Estimation of Functional Aerobic Capacity Using the Sit-to-Stand Test in Older Adults with Heart Failure with Preserved Ejection Fraction.

Authors:  Iván José Fuentes-Abolafio; Adrian Escriche-Escuder; María Rosa Bernal-López; Ricardo Gómez-Huelgas; Michele Ricci; Manuel Trinidad-Fernández; Cristina Roldán-Jiménez; José María Arjona-Caballero; Antonio Ignacio Cuesta-Vargas; Luis Miguel Pérez-Belmonte
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

5.  Association Between 6-Minute Walk Test Distance and Objective Variables of Functional Capacity After Exercise Training in Elderly Heart Failure Patients With Preserved Ejection Fraction: A Randomized Exercise Trial.

Authors:  Sara Maldonado-Martín; Peter H Brubaker; Joel Eggebeen; Kathryn P Stewart; Dalane W Kitzman
Journal:  Arch Phys Med Rehabil       Date:  2016-09-28       Impact factor: 3.966

Review 6.  Chronotropic incompetence: causes, consequences, and management.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 39.918

7.  Maximal exercise test is a useful method for physical capacity and oxygen consumption determination in streptozotocin-diabetic rats.

Authors:  Bruno Rodrigues; Diego M Figueroa; Cristiano T Mostarda; Marcelo V Heeren; Maria-Cláudia Irigoyen; Kátia De Angelis
Journal:  Cardiovasc Diabetol       Date:  2007-12-13       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.